Priapism in Men With Sickle Cell Disease
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD
A Dose and Schedule Finding Trial of AMG 531 for the Treatment of CIT in Subjects With Advanced Non-
A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Tha
A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV
A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small C
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly D
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA
Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individua
Comparison of Rituxan Versus Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphal
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Normal Estradiol
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Smal
Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Trea
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
Multi-Center Human Alert Trial to Prevent DVT and PE
M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patien
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treatin
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients Wi
Study of EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prosta
Treatment for Acute Graft-Versus-Host Disease
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Comprehensive Cancer Control Plan

The Cherokee Nation Comprehensive Cancer Control (CNCCC) Project assists in the development of networks and collaboration that produce an infrastructure for a comprehensive approach to cancer within the Cherokee Nation. Since 2003, coalition members and partners have come together to discuss the burden of cancer in Cherokee Nation. Coalition members and partners include local, regional, state and national representatives committed to identifying areas of cancer concern, planning interventions, prioritizing greatest areas of identified need, and then implementing identified strategies and/or providing needed resources. This is the second edition of the Cherokee Nation Comprehensive Cancer Control Plan and will serve, like the first, as an information resource for health care professionals and community members, as well as a tool for the Cherokee Nation Comprehensive Cancer Control Coalition and its respective entities. The coalition is committed to the process of enhancing infrastructure for comprehensive cancer control in the Cherokee Nation with the ultimate goal of reducing morbidity and mortality among the Cherokee community.